Phosphodiesterase 5 inhibitors

被引:22
作者
Stamford, AW [1 ]
机构
[1] Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA
来源
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 37 | 2002年 / 37卷
关键词
D O I
10.1016/S0065-7743(02)37007-6
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:53 / 64
页数:12
相关论文
共 77 条
[31]   Synthesis and phosphodiesterase 5 inhibitory activity of novel phenyl ring modified sildenafil analogues [J].
Kim, DK ;
Lee, N ;
Lee, JY ;
Ryu, DH ;
Kim, JS ;
Lee, SH ;
Choi, JY ;
Chang, K ;
Kim, YT ;
Im, GJ ;
Choi, WS ;
Kim, TK ;
Ryu, JH ;
Kim, NH ;
Lee, K .
BIOORGANIC & MEDICINAL CHEMISTRY, 2001, 9 (06) :1609-1616
[32]   Synthesis and phosphodiesterase 5 inhibitory activity of new 5-phenyl-1,6-dihydro-7H-pyrazolo[4,3-d] pyrimidin-7-one derivatives containing an N-acylamido group on a phenyl ring [J].
Kim, DK ;
Ryu, DH ;
Lee, N ;
Lee, JY ;
Kim, JS ;
Lee, S ;
Choi, JY ;
Ryu, JH ;
Kim, NH ;
Im, GJ ;
Choi, WS ;
Kim, TK .
BIOORGANIC & MEDICINAL CHEMISTRY, 2001, 9 (07) :1895-1899
[33]  
KIM DK, 2001, Patent No. 0160825
[34]  
Kodama K, 1999, J PHARMACOL EXP THER, V290, P748
[35]   Characterization and effects of methyl-2(4-aminophenyl)-1,2-dihydro-1-oxo-7-(2-pyridinylmethoxy)-4-(3,4,5-trimethoxyphenyl)-3-isoquinoline carboxylate sulfate (T-1032), a novel potent inhibitor of cGMP-binding cGMP-specific phosphodiesterase (PDE5) [J].
Kotera, J ;
Fujishige, K ;
Michibata, H ;
Yuasa, K ;
Kubo, A ;
Nakamura, Y ;
Omori, K .
BIOCHEMICAL PHARMACOLOGY, 2000, 60 (09) :1333-1341
[36]   Genomic origin and transcriptional regulation of two variants of cGMP-binding cGMP-specific phosphodiesterases [J].
Kotera, J ;
Fujishige, K ;
Imai, Y ;
Kawai, E ;
Michibata, H ;
Akatsuka, H ;
Yanaka, N ;
Omori, K .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 262 (03) :866-872
[37]   Expression of three isoforms of cGMP-binding cGMP-specific phosphodiesterase (PDES) in human penile cavernosum [J].
Lin, CS ;
Lau, A ;
Tu, R ;
Lue, TF .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 268 (02) :628-635
[38]   Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3′,5′-cyclic nucleotide phosphodiesterase [J].
Loughney, K ;
Hill, TR ;
Florio, VA ;
Uher, L ;
Rosman, GJ ;
Wolda, SL ;
Jones, BA ;
Howard, ML ;
McAllister-Lucas, LM ;
Sonnenburg, WK ;
Francis, SH ;
Corbin, JD ;
Beavo, JA ;
Ferguson, K .
GENE, 1998, 216 (01) :139-147
[39]   Drug therapy: Erectile dysfunction. [J].
Lue, TF .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (24) :1802-1813
[40]  
MARX D, 2001, Patent No. 0168097